Cohance Lifesciences vs Nifty 50: Returns Compared
- September 11, 2026
- Posted by: Harsh Piplani
- Category: Market
Cohance Lifesciences share price Rs 439.20 on NSE. Cohance Lifesciences vs Nifty 50 over 1 year: -55.92% vs -7.07%. 52-week high Rs 1,008.70, low Rs 266.70.
Quick Answer
Cohance Lifesciences vs Nifty 50 shows Cohance Lifesciences trailing the benchmark on a one-year view, with a return of -55.92% against the Nifty 50’s -7.07%. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock. Investors comparing the two should also weigh Cohance Lifesciences’s trading liquidity, valuation and sector context rather than relying on returns alone.
Cohance Lifesciences vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Cohance Lifesciences trades on the NSE under the symbol COHANCE, and its 1M return of -5.33% compares with the Nifty 50’s -5.04% over the same period.
The Cohance Lifesciences vs Nifty 50 comparison matters because Cohance Lifesciences is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Cohance Lifesciences share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, using NSE closing data.
Click Here – Get Free Investment Predictions
Cohance Lifesciences vs Nifty 50: Performance at a Glance
The table below sets out Cohance Lifesciences vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 11 September 2026.
| Time Frame | Cohance Lifesciences Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | -5.33% | -5.04% | -0.3% pp |
| 3 Months | +3.72% | +0.33% | +3.39% pp |
| 6 Months | +50.57% | -2.63% | +53.2% pp |
| 1 Year | -55.92% (Cohance Lifesciences) | -7.07% (Nifty 50) | -48.86% pp |
On the Cohance Lifesciences vs Nifty 50 scorecard, Cohance Lifesciences has lagged the index over the most recent one-year window. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock.
Check the Univest Screener for live Cohance Lifesciences and Nifty 50 data
Why the Cohance Lifesciences vs Nifty 50 Gap Exists
Cohance Lifesciences’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Cohance Lifesciences vs Nifty 50 return table above.
A second factor behind the Cohance Lifesciences vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Cohance Lifesciences’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.
Download the Univest iOS App or Univest Android App to track Cohance Lifesciences and Nifty 50 live on the go.
Cohance Lifesciences vs Nifty 50: Has Cohance Lifesciences Beaten the Benchmark?
Cohance Lifesciences has not kept pace with the Nifty 50 over the past year, posting a return of -55.92% against the index’s -7.07% over the same period.
Risks of the Cohance Lifesciences vs Nifty 50 Comparison
Reading too much into a Cohance Lifesciences vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Cohance Lifesciences carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 266.70 to Rs 1,008.70 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Cohance Lifesciences vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Cohance Lifesciences vs Nifty 50 record should factor in Cohance Lifesciences’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Cohance Lifesciences outperformed the Nifty 50 in the last year?
Ans. No. Cohance Lifesciences returned -55.92% over the past year while the Nifty 50 returned -7.07% over the same period, based on NSE closing prices to 11 September 2026.
What is the Cohance Lifesciences share price today compared to Nifty 50?
Ans. Cohance Lifesciences share price stood at Rs 439.20 on NSE, while the Nifty 50 traded at 23,238.70 based on the same closing data window.
What is the 52-week high and low of Cohance Lifesciences?
Ans. Cohance Lifesciences’s 52-week high is Rs 1,008.70 and its 52-week low is Rs 266.70, based on NSE data.
Why does Cohance Lifesciences show bigger price swings than the Nifty 50?
Ans. Cohance Lifesciences carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Cohance Lifesciences’s price more sharply than the diversified index, a key reason the Cohance Lifesciences vs Nifty 50 return gap varies across time frames.
Is Cohance Lifesciences a good long-term investment compared to a Nifty 50 index fund?
Ans. Cohance Lifesciences’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Cohance Lifesciences vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
